| 16:30 | Fluocinolone acetonide insert for uveitis: efficacy and experience from a tertiary center | | PLEYER U, KNECHT V A, POHLMANN D, RüBSAM A, MADROSSA D, RAU S, LUSSAC V |
| | 16:37 | Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema (TRIOZ) | | COURET C, QUINTART PA, WEBER M |
| | 16:44 | A novel intravitreal anti-IL-6 monoclonal antibody for uveitic macular edema (UME): preliminary results from the phase 1 DOVETAIL study | | DEUTER C, SHARMA S, SUHLER E, LIN P, PAULY-EVERS M, WILLEN D, HASKOVA Z, SILVERMAN D, FAUSER S, MESQUIDA M, PECK R, HOLMES W, STORTI F, RAUHUT S, GOTT T, PASSEMARD B |
| | 16:51 | Early Pars Plana Vitrectomy in Post- Cataract Surgery Endophthalmitis | | AZADI P |
| | 16:58 | The Humira in non-infectious Uveitis Tapering (HUT) trial | | PICHI F, SMITH S, NERI P |
| | 17:05 | Corticosteroid sparing in birdshot chorioretinopathy: clinical predictors for biologic agents use | | GOUPILLOU P, LECLERCQ M, MURAINE M, GIRSZYN N, GUEUDRY J |
| | 17:12 | Prognostic factors for the introduction of biological therapy in patients with juvenile idiopathic arthritis-related uveitis | | MAPELLI C, MISEROCCHI E, BERETTA GB, MARELLI L, LEONE G, FILOCAMO G, VIOLA F, NASSISI M, MINOIA F |
| | 17:19 | Effectiveness and safety of weekly adalimumab for non-infectious chronic anterior uveitis in children | | GUEUDRY J, HUARD J, RAYMOND S, MIHAILESCU SD, MURAINE M, GRALL LEROSEY M |
| 17:26 | An overview of the management of punctate inner choroidopathy (PIC) at University Hospital Southampton | | KALOGEROPOULOS D, RAHMAN N, CHATZIRALLIS A, HALL N, AFSHAR F |
| | 17:33 | End of Session | |
